Eli Lilly (LLY) recently entered a collaboration with Gate Bioscience to develop molecular gate therapeutics, a move that ...

Eli Lilly is walking through the Gate, inking a deal worth up to $856 million with a biotech aiming to build out a new ...

Eli Lilly (LLY) recently received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for its Alzheimer's drug donanemab, underscoring the company's advancements in a ...

The gene therapy developer is cutting 30% of its workforce. Elsewhere, Abivax secured a major cash infusion, while Novartis and Eli Lilly struck small research deals.

Gate Bioscience is creating a new class of medicines called Molecular Gates, small molecules that selectively eliminate harmful extracellular proteins at their origin: inside the cell.

BRISBANE, Calif., Nov. 1, 2023 /PRNewswire/ -- Gate Bioscience, a biotechnology company creating a new class of medicines called Molecular Gates, today unveiled the company and its scientific ...

Mr. Hatfield brings more than 35 years of leadership experience across emerging biotech and Fortune 500 pharmaceutical companies BRISBANE, Calif. — Gate Bioscience, a biotechnology company developing ...